受国际权威法律评级机构钱伯斯(Chambers and Partners)邀请，环球律师事务所连续第四年为其撰写《全球法律指南》系列中的《药品广告（2022版）》之中国篇。该指南各个国家（地区）的篇章均由钱伯斯排行榜中该专业领域的领先律所撰写，旨在简明扼要地介绍各司法辖区该专业领域法律和实务上的最新发展和趋势。（请点击文末“相关下载”阅读《药品广告（2022版）》全文）

Chambers and Partners, one of the most authoritative international legal ranking agencies, invited Global Law Office to contribute to the Pharmaceutical Advertising 2022 (China Chapter) for the fourth consecutive year. Pharmaceutical Advertising 2022 is a part of the Chambers Global Practice Guide Series. Each country chapter has been written exclusively by contributing authors from leading firms ranked within Chambers and Partners. （Please download the Pharmaceutical Advertising 2022 (China Chapter)  by clicking the button "Download" at the end of this article）

此次《药品广告（2022版）》之中国篇由环球律师事务所周磊、黄旭春、何璇、董秋艳撰写。该指南中着重介绍了中国法律下的药品广告监管框架，药品广告的范围、基本原则、申请、审核、宣传、互联网药品广告等的监管要求，和其反商业贿赂、执法趋势，以及企业日常合规管理中的关注点等。此次撰文结合了环球生命科学及医疗团队在该领域的丰富经验，旨在为企业了解药品广告提供更全面的视角，为企业在中国合法、合规地开展相关活动，提供了有品质、有深度、有层次、可操作性强的实务指引。如果您希望就本指南或者与本指南讨论的内容进一步交流，敬请联系撰文作者。

The Pharmaceutical Advertising 2022 (China Chapter) is drafted by legal professionals at Global Law Office, namely Alan Zhou, Charlene Huang, Samantha He and Sylvia Dong. The guide outlines the regulatory framework of pharmaceutical advertising under PRC law, introduces the regulatory requirements related to definition, principles, application, approval, release, and advertising on the Internet of pharmaceutical advertisement, illustrates the anti-bribery and regulatory enforcement trends, and summarizes key points that companies may consider to prevent and deal with non-compliance conducts in daily operation. By combining the rich experience of the Life Sciences and Healthcare Team of the Global Law Office, this chapter aims to provide a more comprehensive perspective on China's pharmaceutical advertising and practical guidelines for to conduct related business activities in China in a legal and compliant manner. If you have any inquiries or comments about the publication or related issues, please feel free to contact the authors.